A stool culture is more likely to be ordered when a person: 1  Has severe symptoms, dehydration, electrolyte imbalance, and/or other complications. 2  Is very young, elderly, or has a weakened immune system; according to the Centers for Disease Control and Prevention (CDC), diarrhea is a global killer.
Where will Horizon Pharma's stock price be in 2018? 11 equities research analysts have issued 12-month price targets for Horizon Pharma's stock. Their predictions range from $13.00 to $30.00. On average, they expect Horizon Pharma's share price to reach $19.18 in the next twelve months. View Analyst Ratings for Horizon Pharma.
Breidenbach has a 44.4% average return when recommending KITE, and is ranked #4290 out of 4503 analysts. Out of the 15 analysts polled in the past 12 months, 11 rate Kite Pharma stock a Buy, while 4 rate the stock a Hold. With a downside potential of 5%, the stockâs consensus target price stands at $73.55.